AY

Anjali Yadav

Active Director Director DIN 07682213
DIN 07682213 First appointment Dec 2016 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Dec 2016
Shareholding value Locked Premium profile

About Anjali Yadav

Anjali Yadav has 9 years in corporate governance. Holds Director role. Currently with 1 company, including Zyrian Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07682213
Primary Designation Director
First Appointment 26 Dec 2016
Oldest Company Age 10 yrs

Current companies

Company Designation Appointment Founded Status
Director 26 Dec 2016 2016 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Zyrian Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anjali Yadav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anjali Yadav

Anjali Yadav has 9 years in corporate governance. Holds Director role. Currently with 1 company, including Zyrian Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Anjali Yadav is associated with 1 company as Director.

Anjali Yadav has expertise in General Business.

Anjali Yadav has 9 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available